IL140412A0 - L-lys -l-glu dipeptides for pharmaceutical preparations - Google Patents

L-lys -l-glu dipeptides for pharmaceutical preparations

Info

Publication number
IL140412A0
IL140412A0 IL14041299A IL14041299A IL140412A0 IL 140412 A0 IL140412 A0 IL 140412A0 IL 14041299 A IL14041299 A IL 14041299A IL 14041299 A IL14041299 A IL 14041299A IL 140412 A0 IL140412 A0 IL 140412A0
Authority
IL
Israel
Prior art keywords
lys
proposed
stimulating
drug
pharmaceutical preparations
Prior art date
Application number
IL14041299A
Other languages
English (en)
Original Assignee
Obschestvo S Ogranichennoi Otv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Obschestvo S Ogranichennoi Otv filed Critical Obschestvo S Ogranichennoi Otv
Publication of IL140412A0 publication Critical patent/IL140412A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/05—Dipeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Oncology (AREA)
  • Dermatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Treatments For Attaching Organic Compounds To Fibrous Goods (AREA)
  • Bending Of Plates, Rods, And Pipes (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
IL14041299A 1998-06-23 1999-05-27 L-lys -l-glu dipeptides for pharmaceutical preparations IL140412A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
RU98111342/14A RU2139085C1 (ru) 1998-06-23 1998-06-23 Средство, стимулирующее репаративные процессы, и способ его применения
PCT/RU1999/000188 WO1999066948A2 (en) 1998-06-23 1999-05-27 Use of a dipeptide for stimulating repair processes

Publications (1)

Publication Number Publication Date
IL140412A0 true IL140412A0 (en) 2002-02-10

Family

ID=20207251

Family Applications (2)

Application Number Title Priority Date Filing Date
IL14041299A IL140412A0 (en) 1998-06-23 1999-05-27 L-lys -l-glu dipeptides for pharmaceutical preparations
IL140412A IL140412A (en) 1998-06-23 2000-12-19 L-lys -l-glu dipeptides for pharmaceutical preparations

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL140412A IL140412A (en) 1998-06-23 2000-12-19 L-lys -l-glu dipeptides for pharmaceutical preparations

Country Status (11)

Country Link
US (1) US6642201B1 (de)
EP (1) EP1089753B1 (de)
JP (1) JP4489946B2 (de)
AT (1) ATE245434T1 (de)
AU (1) AU776693B2 (de)
CA (1) CA2335362C (de)
CH (1) CH692477A5 (de)
DE (1) DE69909794T2 (de)
IL (2) IL140412A0 (de)
RU (1) RU2139085C1 (de)
WO (1) WO1999066948A2 (de)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030220258A1 (en) 2001-12-21 2003-11-27 Robbert Benner Treatment of ischemic events
US8680059B2 (en) 1998-05-20 2014-03-25 Biotempt B.V. Oligopeptide acetate and formulations thereof
EP1138692A1 (de) 2000-03-29 2001-10-04 Erasmus Universiteit Rotterdam Fragmente des menschlichen Choriongonadotropins als Immunoregulatoren
EP1300418A1 (de) * 2001-10-04 2003-04-09 Erasmus Universiteit Rotterdam Genregulation durch Oligopeptide
USRE43279E1 (en) 2000-03-29 2012-03-27 Biotemp B.V. Compositions capable of reducing elevated blood urea concentration
US7358330B2 (en) 2001-03-29 2008-04-15 Biotempt B.V. Immunoregulatory compositions
RU2177801C1 (ru) * 2001-01-25 2002-01-10 Санкт-Петербургская Общественная Организация "Санкт-Петербургский Институт Биорегуляции И Геронтологии Сзо Рамн" Средство, ингибирующее ангиогенез при заболеваниях органа зрения
US20080318871A1 (en) * 2001-12-21 2008-12-25 Khan Nisar A Treatment of neurological disorders
US7786084B2 (en) 2001-12-21 2010-08-31 Biotempt B.V. Treatment of burns
US7517529B2 (en) * 2003-04-08 2009-04-14 Biotempt B.V. Treatment of type I diabetes
WO2006025352A1 (ja) * 2004-08-30 2006-03-09 Toray Industries, Inc. 分画装置
CA2614084A1 (en) 2005-07-05 2007-01-11 Biotempt B.V. Treatment of tumors
EP1864692A1 (de) * 2006-06-07 2007-12-12 Biotempt B.V. Verwendung von peptiden zum Schutz von Strahlenschäden
RU2301071C1 (ru) * 2006-06-22 2007-06-20 Общество С Ограниченной Ответственностью "Сиа Пептайдс" Гепатопротекторное средство и способ его получения
EP2391424B1 (de) * 2009-01-30 2016-12-28 Beiersdorf AG Kosmetisches oder dermatologisches präparat mit einem zellwachstumsfördernden peptid und einem zellulären komplex
EP2625577B1 (de) 2010-10-08 2019-06-26 Terumo BCT, Inc. Anpassbares verfahren und systeme für züchtung und ernte von zellen in einem hohlfaser-bioreaktorsystem
RU2496511C1 (ru) * 2012-04-20 2013-10-27 Замертон Холдингс Лимитед Фармацевтическая композиция, средство (варианты) и способ профилактики и лечения артрита, остеоартроза и остеохондроза позвоночника (варианты)
RU2517213C2 (ru) * 2012-08-03 2014-05-27 Татьяна Георгиевна Емельянова Средство пептидной структуры, обладающее противовоспалительным, антибактериальным, ранозаживляющим, регенеративным, анальгетическим, противоожоговым действием и лекарственные формы на его основе
RU2521973C1 (ru) * 2013-08-23 2014-07-10 Замертон Холдингс Лимитед Средства для профилактики и лечения заболеваний суставов и способы их применения
EP3068866B1 (de) 2013-11-16 2018-04-25 Terumo BCT, Inc. Zellenexpansion in einem bioreaktor
EP3613841B1 (de) 2014-03-25 2022-04-20 Terumo BCT, Inc. Passives ersetzen von medien
EA025549B1 (ru) 2014-09-09 2017-01-30 Замертон Холдингс Лимитед Композиция и средства для профилактики и лечения заболеваний суставов и позвоночника и способы их применения
CN106715676A (zh) 2014-09-26 2017-05-24 泰尔茂比司特公司 按计划供养
WO2017004592A1 (en) 2015-07-02 2017-01-05 Terumo Bct, Inc. Cell growth with mechanical stimuli
CN109415696A (zh) 2016-05-25 2019-03-01 泰尔茂比司特公司 细胞扩增
US11104874B2 (en) 2016-06-07 2021-08-31 Terumo Bct, Inc. Coating a bioreactor
US11685883B2 (en) 2016-06-07 2023-06-27 Terumo Bct, Inc. Methods and systems for coating a cell growth surface
RU2627669C1 (ru) * 2016-07-20 2017-08-09 федеральное государственное бюджетное научное учреждение "Федеральный центр токсикологической, радиационной и биологической безопасности" (ФГБНУ "ФЦТРБ-ВНИВИ") Способ получения продуктов метаболизма бифидобактерий для лечения комбинированного радиационно-термического поражения организма и способ лечения комбинированного радиационно-термического поражения организма
CN117247899A (zh) 2017-03-31 2023-12-19 泰尔茂比司特公司 细胞扩增
US11624046B2 (en) 2017-03-31 2023-04-11 Terumo Bct, Inc. Cell expansion
CN113004370B (zh) * 2021-02-09 2022-06-17 宁波绿之健药业有限公司 一种具有缓解高尿酸血症和调节肠道菌群的二肽及其应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DD248961A1 (de) 1984-05-22 1987-08-26 Akad Wissenschaften Ddr Verfahren zur herstellung wundheilungsfoerdernder praeparationen
WO1995003067A1 (en) * 1993-07-21 1995-02-02 Khavinson Vladimir Khatskelevi Pharmaceutical with immunomodulating activity
RU2080120C1 (ru) 1994-07-19 1997-05-27 Совместное русско-американское акционерное общество закрытого типа "Неофарм" Средство, обладающее иммуномодулирующей активностью

Also Published As

Publication number Publication date
JP2002518459A (ja) 2002-06-25
CH692477A5 (de) 2002-07-15
EP1089753A2 (de) 2001-04-11
CA2335362A1 (en) 1999-12-29
AU4536999A (en) 2000-01-10
IL140412A (en) 2007-06-17
CA2335362C (en) 2012-11-20
ATE245434T1 (de) 2003-08-15
DE69909794D1 (de) 2003-08-28
RU2139085C1 (ru) 1999-10-10
JP4489946B2 (ja) 2010-06-23
WO1999066948A3 (en) 2000-03-23
US6642201B1 (en) 2003-11-04
DE69909794T2 (de) 2004-06-09
AU776693B2 (en) 2004-09-16
WO1999066948A2 (en) 1999-12-29
EP1089753B1 (de) 2003-07-23

Similar Documents

Publication Publication Date Title
IL140412A0 (en) L-lys -l-glu dipeptides for pharmaceutical preparations
EP1033998A4 (de) Methode zur unterdrückung von beta-amyloid-verwandten veränderungen in alzheimer
CA2264852A1 (en) Use of methylphenidate or a pharmaceutically acceptable salt thereof
PL338982A1 (en) Drug for improving duration of muscle action or for treating muscular disorders or diseases
NZ336055A (en) An oral sustained release formulation of opioids
RU95113492A (ru) Терапевтическая комбинация, содержащая человеческий интерферон, его применение, фармацевтический препарат, упаковка и способ лечения
DE69634609D1 (de) Analgesiche synergie durch gleichzeitige verabreichung von subanalgesichen doseneines mu-opioidanagonisten und eines kappa - 2- opioidanagonisten
IL146432A0 (en) A tetrapeptide and a pharmaceutical composition containing the same
MX9709644A (es) Dispositivo para el suministro transdermico por electrotransporte de fentanilo y sufentanilo.
BR9510168A (pt) Composto poliaminoácido composição forma unitária de dosagem e método par epreparar uma composição
PT946151E (pt) Forma de dosagem de dose crescente
WO2001068125A3 (en) Methods and compositions for the treatment and prevention of erectile dysfunction
IL136733A0 (en) Pharmaceutical composition containing sibutramine and orlistat
EA200700178A1 (ru) Пептид, обладающий стресспротекторным действием, фармацевтическая композиция на его основе и способ ее применения
EP1304108A3 (de) Anti-arrhythmische Zusammensetzungen und Behandlungsverfahren
ATE513845T1 (de) Peptidsubstanz mit immunogeroprotektiver wirkung, darauf basierende pharmazeutische zusammensetzung und verfahren zu ihrer anwendung
BG103905A (en) New bpc peptide salts with organoprotective activity, method for their preparation and application in medicine
WO2007139433A8 (en) Peptide substance normalizing the metabolism in osseous and cartilaginous tissues, pharmaceutical composition on its base and the method of its application
WO2002030955A3 (en) Tetrapeptide stimulating functional activity of hepatocytes and its therapeutical use
UA41326C2 (uk) Фармацевтична композиція для профілактики або лікування вірусних захворювань, засіб для профілактики або лікування вірусних захворювань
Millinger Neutral amino acid therapy for the management of chronic pain
US20200339627A1 (en) Endomorphin-2, tetrapeptide derivatives thereof, and uses thereof
EA200601581A1 (ru) Пептид, стимулирующий регенерацию ткани печени, фармацевтическая композиция на его основе и способ ее применения
CA2368184A1 (en) Method and means for treating post-polio syndrome
MD1469F1 (en) Method of treatment of the burn shock

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed